Encouraging Appropriate Patients
with RA to Take Biologics: The Tipping Point
Independently
Commissioned by the
1Q2014Tipp...
About the QRC Working Group
•  The QRC Working Group was founded in 2013 as a collaborative effort to conduct
cutting-edge...
2014 QRC Working Group: Authors
•  Pat Sabena – Sabena Qualitative Research 	

–  Specializing in healthcare research for ...
Independently funded
This QRC Working Group Syndicated Report was	

1Q2014Tipping Point for Biologics in RA ©2014 QRC Work...
Table of Contents	

Business Purpose and Objectives ………………………… 	

Research Methodology ……………………………………	

Executive Summary ...
Business Purpose and Objectives
Background and Business Purpose:	

•  As Rheumatoid Arthritis (RA) advances, Rheumatologis...
Research Methodology	

•  Research sample contains 89 respondents: 	

–  31 Rheumatologists	

–  25 Patients who are curre...
Excerpts
Independently commissioned by the
1Q2014Tipping Point for Biologics in RA ©2014 QRC Working Group
Rheumatologists
Independently commissioned by the
1Q2014Tipping Point for Biologics in RA ©2014 QRC Working Group
When	
  Rheumatologists	
  think	
  about	
  RA	
  …	
  
Their	
  focus	
  is	
  on	
  their	
  Own	
  Emo<ons	
  and	
  t...
The Best Things About Treating RA...	

•  Rheumatologists report that the best things about treating RA today are:	

–  So...
Rheumatologists cite their Frustrations about Treating RA	

•  Rheumatologists lament that the worst things about treating...
CONVERTING	
  PATIENTS	
  FROM	
  
DMARDS	
  TO	
  BIOLOGICS	
  
Rheumatologists provide their perspectives on the tipping...
Digging Deep into Physician-Patient Attitudes and Conversations
Encouraging Appropriate Patients with RA to Take Biologics: The Tipping Point
Encouraging Appropriate Patients with RA to Take Biologics: The Tipping Point
Encouraging Appropriate Patients with RA to Take Biologics: The Tipping Point
Encouraging Appropriate Patients with RA to Take Biologics: The Tipping Point
Encouraging Appropriate Patients with RA to Take Biologics: The Tipping Point
Encouraging Appropriate Patients with RA to Take Biologics: The Tipping Point
Encouraging Appropriate Patients with RA to Take Biologics: The Tipping Point
Encouraging Appropriate Patients with RA to Take Biologics: The Tipping Point
Encouraging Appropriate Patients with RA to Take Biologics: The Tipping Point
Encouraging Appropriate Patients with RA to Take Biologics: The Tipping Point
Encouraging Appropriate Patients with RA to Take Biologics: The Tipping Point
Upcoming SlideShare
Loading in …5
×

Encouraging Appropriate Patients with RA to Take Biologics: The Tipping Point

246 views
168 views

Published on

Encouraging Appropriate Patients
with RA to Take Biologics: The Tipping Point

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
246
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
5
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Encouraging Appropriate Patients with RA to Take Biologics: The Tipping Point

  1. 1. Encouraging Appropriate Patients with RA to Take Biologics: The Tipping Point Independently Commissioned by the 1Q2014Tipping Point for Biologics in RA ©2014 QRC Working Group This is an independently funded syndicated report.The QRC Working Group owns all rights to this report.This report may not be distributed outside of the purchasing organization without written permission from the QRC Working Group
  2. 2. About the QRC Working Group •  The QRC Working Group was founded in 2013 as a collaborative effort to conduct cutting-edge research on timely and compelling topics within the healthcare field •  The QRC Working Group consists of four professional colleagues with extensive healthcare experience.We bring together our ability to identify rich, actionable insights through progressive research techniques, tools and methodologies gained during our respective careers as well as our leadership in the Qualitative Research Consultants Association •  Our Syndicated Research Series is designed to heighten awareness and acceptance of innovative qualitative techniques. These techniques are proven to be very effective in uncovering prescriber and consumer behaviors and emotions while addressing common pharma business issues •  The 2014 Syndicated Report is dedicated to those who suffer from the debilitating disease of Rheumatoid Arthritis 1 1Q2014Tipping Point for Biologics in RA ©2014 QRC Working Group
  3. 3. 2014 QRC Working Group: Authors •  Pat Sabena – Sabena Qualitative Research –  Specializing in healthcare research for over 40 years, Pat is a recognized leader in qualitative research.A pioneer of innovative projective tools, techniques and research best practices, Pat has taught award- winning peer workshops across the globe. A three-term President of (QRCA) the Qualitative Research Consultants Association, she has personally conducted over 11,000 focus groups /IDIs during her career –  Contact: 203.292.9680, psabena@qual.com •  SusanThornhill –Thornhill Associates –  Susan brings over 14 years of experience working with a broad range of qualitative research clients. She specializes in creative approaches to customer immersion, understanding the patient journey and strategic brainstorming, and served as a recent Past President of QRCA –  Contact: 310.318.2600, susan@thornhill-associates.com •  Camille Carlin – Camille Carlin Qualitative Research –  Camille has over 25 years of experience conducting extensive qualitative research with physicians, nurses, dietitians, pharmacists and consumers in the healthcare industry. She is an active member and presenter at QRCA Conferences –  Contact: 914.332.8647, c.carlin@att.net •  Glenn Naphy – Calign, Inc. –  Managing Director of Calign Inc., an innovative marketing consulting and marketing research firm specializing in the healthcare industry, Glenn brings a unique perspective with his 22 years of experience both on the client and supplier sides of medical research. He currently serves as QRCA Southern California ChapterTreasurer –  Contact: 888.729.1139 x21, glenn.naphy@caligninc.com 2 1Q2014Tipping Point for Biologics in RA ©2014 QRC Working Group
  4. 4. Independently funded This QRC Working Group Syndicated Report was 1Q2014Tipping Point for Biologics in RA ©2014 QRC Working Group and is the first in a series of syndicated reports   3        
  5. 5. Table of Contents Business Purpose and Objectives ………………………… Research Methodology …………………………………… Executive Summary ……………………………………… Detailed Reports ………………………………………… Rheumatologists Executive Summary ……………… Rheumatologists Detailed Report ………………… “Considering” Biologics Executive Summary ……… “Considering” Biologics Detailed Report …………… “On” Biologics Executive Summary ………………… “On” Biologics Detailed Report …………………… 4 1Q2014Tipping Point for Biologics in RA ©2014 QRC Working Group 5 6 9 12 13 20 73 82 135 143
  6. 6. Business Purpose and Objectives Background and Business Purpose: •  As Rheumatoid Arthritis (RA) advances, Rheumatologists and patients have an active dialogue surrounding the issue of when and if the patient should go on a biologic. By gaining a better understanding of the physician-patient dialogue, we have a clearer view of the struggles patients and physicians experience during this point on the patient journey •  A clearer understanding of the physician-patient dialogue helps the pharmaceutical industry identify with the needs of the patient and physician, thereby improving the transition from biologic naïve to treatment with a biologic Objectives: •  Determine the tipping points for patients and physicians to accept and prescribe biologics for appropriate patients with RA •  Identify the levers that will convert a biologic naïve patient to a biologic 5 1Q2014Tipping Point for Biologics in RA ©2014 QRC Working Group
  7. 7. Research Methodology •  Research sample contains 89 respondents: –  31 Rheumatologists –  25 Patients who are currently considering a biologic but are reluctant –  33 Patients who have accepted and are currently taking a biologic •  Qualification criteria focused on: –  Rheumatologists in practice 3-33 years, experienced users of biologics, and with an ample patient case load for rheumatoid arthritis –  “Considering” Patients had to have moderate to severe RA and have at least one discussion regarding initiating a biologic within the last 12 months –  “On” biologic patients had to have moderate to severe RA and have been started on a biologic within the last 12 months •  Multiple projective techniques were used to facilitate a deep understanding of the drivers and barriers to theTipping Point – accepting a biologic •  A total of 29 tele-depth interviews (TDIs) were conducted •  A total of 60 interviews were conducted using QualBoard™ - an interactive bulletin board platform 6 1Q2014Tipping Point for Biologics in RA ©2014 QRC Working Group
  8. 8. Excerpts Independently commissioned by the 1Q2014Tipping Point for Biologics in RA ©2014 QRC Working Group
  9. 9. Rheumatologists Independently commissioned by the 1Q2014Tipping Point for Biologics in RA ©2014 QRC Working Group
  10. 10. When  Rheumatologists  think  about  RA  …   Their  focus  is  on  their  Own  Emo<ons  and  their  Pa<ents’  Journey  to  Remission   *The larger the word the more often it represents individual mentions 9 1Q2014Tipping Point for Biologics in RA ©2014 QRC Working Group
  11. 11. The Best Things About Treating RA... •  Rheumatologists report that the best things about treating RA today are: –  So many new treatment options really make a difference in improving many lives –  Our ability to stop or significantly slow the destructive process of the disease –  I can really impact people's lives with the ever increasing armamentarium and efficacy –  Instilling hope after periods of pre-diagnosis anxiety and uncertainty –  We can now put this disease in remission if it is caught early and treated aggressively –  Ability to affect meaningful change in the disease process and achieve remission –  To make a difference in the quality of people's lives to give them their life back •  "Ten years ago we had prednisone, methotrexate, sulfasalizine, and two biologics. Now we have seven biologics with five of them having different mechanisms of action...now I can switch from a TNF inhibitor to IL6 inhibitor to a T-cell inhibitor to a B-cell inhibitor." Dr. David •  "The best thing about treating RA is the satisfaction when patients improve and the pleasure in seeing them able to do things that they have not been able to do before because of their symptoms." Dr. Jeff •  "The best thing about treating RA is the satisfaction you get with seeing some patients respond, improve, and reverse the course that they were on." Dr. Frank 10 Advances in drug therapy help patients achieve “remission” and “good QoL” 1Q2014Tipping Point for Biologics in RA ©2014 QRC Working Group
  12. 12. Rheumatologists cite their Frustrations about Treating RA •  Rheumatologists lament that the worst things about treating RA today are: –  The bureaucratic hassles we sometimes have to put up with to get patients treated properly –  Frustration when insurance companies often erect barriers to diagnosis and treatment –  Cost of biologics are often too expensive or require a lot of time and effort to get approved –  Some poor patients even with insurance cannot afford co-pays –  Dealing with patients' anxiety about potential adverse reactions of medications –  Patients' advanced disease diagnosed years earlier which could have been prevented –  The frustration and challenge of a few patients who do not respond or respond inadequately even to biologics –  Ignorance of urgent care providers, orthopedic surgeons and PCPs who do not refer patients early enough to Rheumatologists –  TV commercials listing the side effects of newer drugs without priority or contexts 11 Rheums cite “roadblocks” to treatment, side effect fears, and lack of response 1Q2014Tipping Point for Biologics in RA ©2014 QRC Working Group
  13. 13. CONVERTING  PATIENTS  FROM   DMARDS  TO  BIOLOGICS   Rheumatologists provide their perspectives on the tipping point 1Q2014Tipping Point for Biologics in RA ©2014 QRC Working Group 12  
  14. 14. Digging Deep into Physician-Patient Attitudes and Conversations

×